However, in later stages of the disease when the evolutionary pressure again increases (i.e., in the immune clearance phase), continuous hepatitis activity and hepatic flares might result in declining serum HBV-DNA levels and eventually lead to HBeAg seroconversion and development of anti-HBe (27). This evidence concerns the gene HBE1 and Hepatitis.